Problem:
Antiretroviral therapy (ART) is essential for all individuals diagnosed with HIV and should be initiated as soon as possible-ideally within 7 days of diagnosis, including same-day starts-to enhance health outcomes, reduce mortality rates, and prevent transmission. The significance of early ART initiation is underscored by the landmark START trial, which demonstrated that starting ART immediately in patients with CD4 counts greater than 500 cells/μL led to a significant reduction in serious AIDS-related events, serious non-AIDS events, and mortality, without an increase in grade 4 adverse events. This established the principle of universal treatment regardless of CD4 count. Early ART also substantially lowers the risk of HIV transmission, as reflected in the "Undetectable = Untransmittable" principle, while preserving immune function and improving long-term survival, with life expectancy for those on ART approaching that of the general population. Current management guidelines, including the 2024 IAS-USA Panel and HHS OARAC guidelines, recommend ART regimens based on second-generation integrase strand transfer inhibitors (InSTIs) due to their high efficacy (over 90% viral suppression), excellent tolerability, high barrier to resistance, and minimal drug interactions. Recommended initial regimens include Bictegravir/tenofovir alafenamide/emtricitabine (BIC/TAF/FTC), a single-tablet regimen classified as an "A-I" recommendation. Rewrite more concisely. Need Assignment Help?